Further, results from our lab showed that this CD133+ population was enriched upon stress conditions like nutritional deprivation, hypoxia as well as chemotherapeutic stress4–6, and was identified as a “tumor initiating cell” even though it was not the cell of origin for pancreatic cancer. The gene discussed is PROM1; the disease is pancreatic neoplasm.